Potential clinical benefit of donor lymphocyte infusion in the treatment of refractory invasive fungal pneumonia [3]

Bone Marrow Transplantation

Volumn 40, Issue 6, 2007, Pages 599-601

  Ilyas, C ^a   Forrest, G N ^b   Akpek, G ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; BUSULFAN; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LYMPHOCYTE ANTIBODY; METHOTREXATE; METHYLPREDNISOLONE; POSACONAZOLE; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; BACTERIAL INFECTION; BRONCHOSCOPY; CASE REPORT; CD4 CD8 RATIO; CLINICAL EFFECTIVENESS; COMPUTER ASSISTED TOMOGRAPHY; DONOR LYMPHOCYTE INFUSION; DRUG MEGADOSE; ERYTHROCYTE TRANSFUSION; GRAFT VERSUS HOST REACTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LETTER; LEUKOPENIA; LOW DRUG DOSE; LUNG MYCOSIS; MALE; NAUSEA AND VOMITING; PNEUMONIA; PRIORITY JOURNAL; SHORT TANDEM REPEAT; THROMBOCYTE TRANSFUSION; TRANSBRONCHIAL BIOPSY; VIRUS INFECTION;

ACUTE DISEASE; AGED; ANTIFUNGAL AGENTS; BLOOD DONORS; DRUG RESISTANCE, FUNGAL; HUMANS; LEUKEMIA, MYELOID; LUNG DISEASES, FUNGAL; LYMPHOCYTE TRANSFUSION; MALE;

EID: 34548525025     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705773     Document Type: Letter

References (6)

1. Kolb HJ, Schmid C, Barrett AJ, Schendel DJ. Graft-versus-leukemia reactions in allogeneic chimeras. Blood 2004; 103: 767-776.
2. Amrolia PJ, Muccioli-Casadei G, Huls H, Adams S, Durett A, Gee A et al. Adoptive immunotherapy with allodepleted donor T-cells improves immune reconstitution after haploidentical stem cell transplantation. Blood 2006; 108: 1797-1808.
3. Bellucci R, Alyea EP, Weller E, Chillemi A, Hochberg E, Wu CJ et al. Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma. Blood 2002; 99: 4610-4617.
4. Ferra C, Rodriguez-Luaces M, Gallardo D, Encuentra M, Martin-Henao GA, Peris J et al. Individually adjusted prophylactic donor lymphocyte infusions after CD34-selected allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant 2001; 28: 963-968.
5. de Lima M, Bonamino M, Vasconselos Z, Colares M, Diamond H, Zalcberg I et al. Prophylactic donor lymphocyte infusion after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: High remission rate among poor prognosis patients at the expense of graft versus host disease. Bone Marrow Transplant 2001; 27: 73-78.
6. Schmid C, Schleuning M, Ledderose G, Tischer J, Kolb HJ. Sequential regimen of chemotherapy, reduced intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol 2005; 23: 5675-5687.